1. Which of the following is not likely to play a role in clotting of blood?
a) Fibrinogen
b) Platelets
c) Clotting factors
d) Antibodies
d
2. Which of the following clotting factor is deficient in people suffering from haemophilia A?
a) Factor V
b) Factor VI
c) Factor IX
d) Factor VIII
d
3. In majority of the cases haemophilia A is inherited as an X-linked recessive trait.
a) False
b) True
b
4. Which of the following is a bypassing agent, that circumvents the inhibitor to provide hemostasis?
a) Recombinant factor X (FX)
b) Recombinant factor IX (FIX)
c) Recombinant activated factor VIII (FVIIIa)
d) Recombinant activated factor VII (FVIIa)
d
5. Most early gene therapy studies were focused on haemophilia B, despite the fact that haemophilia B accounts for only 20 % of all haemophilia cases.
a) False
b) True
b
6. Which of the following is the first non-factor prophylactic bypassing agent that was recently approved for haemophilia A patients with and without inhibitors?
a) Tocilizumab
b) Itolizumab
c) Hemilizumab
d) Emicizumab
d
7. Which of the following mostly activates FVIII during coagulation?
a) Plasmin
b) Furin
c) Fibrin
d) Thrombin
d
8. What is the molecular weight of full length FVIII protein?
a) 170 kDa
b) 210 kDa
c) 310 kDa
d) 280 kDa
d
9. Factor VIII predominantly circulates as a homodimer.
a) True
b) False
b
10. Which of the following clotting factor is deficient in people suffering from haemophilia B?
a) Factor V
b) Factor VII
c) Factor VIII
d) Factor IX
d
11. Which of the following domain is the cleavage site for furin enzyme?
a) A domain
b) A2 domain
c) C1 domain
d) B domain
d
12. The FVIII heavy chain and light chain dissociate after cleavage by the furin.
a) True
b) False
b
13. Which of the following is responsible for the activation of factor X (FX) during sustained coagulation?
a) Activated Factor V (FVa)
b) Activated Factor VIII (FVIIIa)
c) Activated Factor XII (FXIIa)
d) Activated Factor IX (FIXa)
d
14. Where in the cell does the cleavage of B domain (of FVIII) occurs by protease furin?
a) Endoplasmic Reticulum
b) Mitochondria
c) cis region of golgi apparatus
d) trans region of golgi apparatus
d
15. Which of the following factor is also known as an anti-hemophilic factor?
a) Factor VII
b) Factor V
c) Factor VI
d) Factor VIII
d
Sanfoundry Global Education & Learning Series – Protein Engineering.
To practice all areas of Protein Engineering,  here is complete set of 1000+ Multiple Choice Questions and Answers.
Participate in the Sanfoundry Certification contest to get free Certificate of Merit. Join our social networks below and stay updated with latest contests, videos, internships and jobs!
Telegram | Youtube | LinkedIn | Instagram | Facebook | Twitter | Pinterest
Youtube | LinkedIn | Instagram | Facebook | Twitter | Pinterest
« Prev - Protein Engineering Questions and Answers – Applications – Engineering Therapeutic Hormone : Insulin» Next - Protein Engineering Questions and Answers – Applications – Engineering Blood Clotting Factor VIII – 2 
